From Genentech Redux? Roche Buys Majority Stake in Foundation Medicine:

Mike Pellini

Mike Pellini—

Mike Pellini is the CEO of Foundation Medicine

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

From Our Editors · Podcast
Xcelerating Life Sciences Boston: The Highlights Podcast
Learn what's fueling Boston's biotech and digital health investment and partnership opportunities

Sponsored · Whitepaper
COVID-19 Special Report: Sustaining Clinical Research During the Crisis
Leveraging technology & expertise to ensure a continual journey from trials to treatments
PRA Health Sciences

Xconomy on Demand

We offer a number of ways to subscribe for free!